← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Roche Palo Alto, Llc
Palo Alto, CA
$2,964,481
Total funding
3
Grants
Funding over time
peak $534.7K · FY2005–08$1M$750K$500K$250K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$2,964,481 · 3
By mechanism
R01$2,964,481 · 3
Investigators at Roche Palo Alto, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
NOVEL SNP-ALLELE GENOTYPING METHOD$397,188
R01 · FY2000 · HG
NOVEL SNP-ALLELE GENOTYPING METHOD$309,327
R01 · FY2002 · HG
NOVEL SNP-ALLELE GENOTYPING METHOD$297,793
R01 · FY2001 · HG
Pharmacogenetic Analysis in Mice$290,533
R01 · FY2006 · GM
Pharmacogenetic Analysis in Mice$288,917
R01 · FY2005 · GM
Pharmacogenetic Analysis in Mice$280,560
R01 · FY2004 · GM
Molecular mechanisms of autoreactive B cell activation$244,125
R01 · FY2006 · AI
Molecular mechanisms of autoreactive B cell activation$237,045
R01 · FY2007 · AI
Molecular mechanisms of autoreactive B cell activation$232,541
R01 · FY2008 · AI
Molecular mechanisms of autoreactive B cell activation$204,316
R01 · FY2005 · AI
NOVEL SNP-ALLELE GENOTYPING METHOD$121,136
R01 · FY2001 · HG
NOVEL SNP-ALLELE GENOTYPING METHOD$61,000
R01 · FY2002 · HG